Anaplastic Malignant Neoplasm — Trials

Anaplastic Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,019 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 546
Recruiting: 290
Ph III recruiting: 18
Growth YoY: +34.5%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (323)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05900908	Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy(PATHWAyS)	withdrawn	Phase 4	0	GT Medical Technologies, Inc.INDUSTRY	0	Apr 10, 2025	clinicaltrials
NCT02487316	A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib	withdrawn	Phase 4	0	Jun ZhuOTHER	1	Dec 30, 2016	clinicaltrials